PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Molecular Biomedical Sciences and Comparative Medicine Institute, North Carolina State University, Raleigh, NC, USA.\', \'Joint Department of Biomedical Engineering, The University of North Carolina at Chapel Hill and North Carolina State University, Chapel Hill, NC, USA.\', \'BreStem Therapeutics Inc., Raleigh, NC, USA.\', \'Bioqual Inc., Rockville, MD, USA.\', \'Division of Pulmonary Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.\', \'Department of Molecular Biomedical Sciences and Comparative Medicine Institute, North Carolina State University, Raleigh, NC, USA. ke_cheng@ncsu.edu.\', \'Joint Department of Biomedical Engineering, The University of North Carolina at Chapel Hill and North Carolina State University, Chapel Hill, NC, USA. ke_cheng@ncsu.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41565-021-00923-2
?:hasPublicationType
?:journal
  • Nature nanotechnology
is ?:pmid of
?:pmid
?:pmid
  • 34140674
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 20.612
?:rankingScore_hIndex
  • 263
is ?:relation_isRelatedTo_publication of
?:title
  • Cell-mimicking nanodecoys neutralize SARS-CoV-2 and mitigate lung injury in a non-human primate model of COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all